运动疗法联合放射治疗在癌症患者中的系统综述
结果显示联合方案安全且耐受良好,在生活质量、疲乏、情绪/抑郁、焦虑及身体功能方面均有统计学显著改善。
要点
- 同步运动疗法联合放疗安全且耐受良好,可接受性和完成率较高。
- 联合方案在生活质量、疲乏、情绪/抑郁、焦虑等患者报告结局方面有显著改善。
- 身体功能在全部16项相关研究中均显示统计学显著改善。
核心结论
- 同步运动疗法联合放疗安全且耐受良好,并改善患者报告结局和身体功能。
- 目前缺乏针对转移性癌症患者评估生存及比较不同运动方案疗效的研究。
研究设计与样本
- 采用PICOS/PRISMA选择协议检索PubMed、CINAHL和Cochrane Review的前瞻性随机对照试验。
- 纳入评估同步运动疗法联合放疗、样本量>10例且至少1个研究臂的研究。
- 患者肿瘤类型分布:局限性乳腺癌67.1%、前列腺癌27.4%、头颈癌2.8%、脊柱转移瘤2.8%。
- 计算可接受性、可行性和安全性率;患者报告结局采用研究特定指标评估;身体功能定义为力量或活动范围改善;统计学显著改善定义为P<.05。
主要发现
- 在3385例被邀请参与运动疗法的患者中,1864例(55.1%)接受治疗。
- 接受治疗的患者中,1563例(83.9%)完成了试验。
- 生活质量在15项研究中14项显示统计学显著改善。
- 疲乏在16项研究中12项、情绪/抑郁在13项中9项、焦虑在7项中6项显示统计学显著改善。
- 身体功能在16项研究中全部16项显示统计学显著改善。
关键数值与推荐
- 统计学显著改善定义为P<.05。
- 身体功能改善定义为力量或活动范围改善。
- 可接受性以接受运动疗法患者占被邀请患者的比例计算(1864/3385,55.1%)。
- 可行性以完成试验患者占接受治疗患者的比例计算(1563/1864,83.9%)。
临床怎么用
- 同步运动疗法联合放疗可作为安全且耐受良好的辅助干预,用于改善患者报告结局和身体功能。
- 当前NCCN指南缺乏同步放疗与运动疗法的推荐,本系统综述结果可为临床实践提供参考。
- 对转移性癌症患者,现有证据尚不足以评估运动疗法联合放疗对生存的影响。
局限性
- 纳入研究以局限性乳腺癌和前列腺癌患者为主,头颈癌和脊柱转移瘤患者占比较小。
- 患者报告结局采用研究特定指标评估,缺乏统一标准化测量。
- 需要更多针对转移性癌症患者的研究以评估生存结局并比较不同运动方案的疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Exercise therapy (ET) is shown to improve toxicity and surrogates of survival for patients receiving chemotherapy. Current National Comprehensive Cancer Network (NCCN) guidelines lack recommendations for concurrent radiation therapy (RT) and ET. The main objective was to determine the impact of concurrent ET + RT with respect to (1) acceptability, feasibility, safety; and (2) to demonstrate how incorporating ET in cancer treatment can enhance patient-reported outcomes (PROs) and physical function-defined as strength or exercise capacity. METHODS AND MATERIALS: A PICOS/PRISMA selection protocol was used to search PubMed, Cumulative Index of Nursing and Allied Health Literature (CINAHL), and Cochrane Review for prospective randomized controlled trials evaluating concurrent ET + RT, including >10 patients and with 1 or more study arms. Acceptability, feasibility, and safety rates were calculated. PROs were assessed with study-specific metrics. Physical function was defined as improvements in strength or range of motion. Statistically significant improvement was defined by P <.05. RESULTS: Twenty-six of 693 screened studies including 1563 patients (831 receiving exercise, 732 controls) with localized breast cancer (67.1% of patients), prostate cancer (27.4%), head and neck cancers (2.8%), and spinal metastases (2.8%) were assessed. Objective 1: Among 3385 patients approached for ET, 1864 (55.1%) accepted the treatment; of those, 1563 patients (83.9%) completed the trials. Objective 2: Statistical improvements were noted in these PROs: quality of life (14 of 15 studies), fatigue (12 of 16 studies), mood/depression (9 of 13), and anxiety (6 of 7). Physical function improved statically in 16 of 16 studies. CONCLUSIONS: Combination ET + RT is safe and well-tolerated with improvements in PROs and physical function. Additional studies are needed in patients with metastatic cancers to assess survival and to compare effectiveness of different exercise regimens.
引用
- Zaorsky NG, Allenby T, Lin J, et al. Exercise Therapy and Radiation Therapy for Cancer: A Systematic Review. Int J Radiat Oncol Biol Phys. 2020. PMID: 33220396. doi:10.1016/j.ijrobp.2020.11.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。